This pilot trial studies how well contrast enhanced mammography works in diagnosing patients with suspicious breast findings. Diagnostic procedures, such as contrast enhanced mammography, may help to reclassify findings seen on diagnostic mammography and ultrasound as benign or likely benign with what would otherwise require biopsy for confirmation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Sensitivity of contrast enhanced mammography (CEM) to classify a lesion as benign, probably benign, or suspicious
Timeframe: Up to 1 year
Sensitivity of MM to classify a lesion as benign, probably benign, or suspicious
Timeframe: Up to 1 year
Sensitivity of US to classify a lesion as benign, probably benign, or suspicious
Timeframe: Up to 1 year
Specificity of CEM to classify a lesion as benign, probably benign, or suspicious
Timeframe: Up to 1 year
Specificity of MM to classify a lesion as benign, probably benign, or suspicious
Timeframe: Up to 1 year
Specificity of US to classify a lesion as benign, probably benign, or suspicious
Timeframe: Up to 1 year
False negative rate of CEM
Timeframe: Up to 1 year
False negative rate of MM
Timeframe: Up to 1 year
False negative rate of US
Timeframe: Up to 1 year
False positive rate of CEM
Timeframe: Up to 1 year
False positive rate of MM
Timeframe: Up to 1 year
False positive rate of US
Timeframe: Up to 1 year